NIOX Group PLC (NIOX)

Industry Medical Devices


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

61.00p

Buy

61.80p

arrow-up0.20p (+0.33%)

Prices updated at 15 May 2026, 16:38 BST
| Prices minimum 15 mins delay
|
Prices in GBX

Circassia Pharmaceuticals PLC is a biotechnology company. It is engaged in the development and commercialization of range of therapies for asthma and chronic obstructive pulmonary disease.

Income statement

20242025
42m49m
30m34m
8m11m
18.4221.97
4m7m
12m15m
Sales, General and administrative20m20m
Interest expenses100,000-
Provision for income taxes4m4m
Operating expenses23m23m
Income before taxes8m11m
Net income available to common shareholders4m7m
0.00880.0169
Net interest income700,000200,000
Advertising and promotion--
Net investment income, net-500,000-300,000
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.00830.0164
Free cash flow per share0.02660.0385
Book value/share0.20550.1541
Debt equity ratio0.0134450.007396

Balance sheet

20242025
Current assets21m31m
Current liabilities8m8m
Total capital60m68m
Total debt2m1m
Total equity60m68m
Total non current liabilities--
Loans--
Total assets68m76m
Total liabilities--
Cash and cash equivalents11m20m
Common stock398m418m

Cash flow

20242025
Cash at beginning of period20m11m
Cash dividends paid-4m-5m
16m14m
Investments (gains) losses-1m-1m
11m20m
Net income--
17m15m
-1m-1m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.